Exact Mass: 423.1592

Exact Mass Matches: 423.1592

Found 71 metabolites which its exact mass value is equals to given mass value 423.1592, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Methyl-2,3,7,8-tetramethoxy-5,6-dihydrobenzophenathridine-6-ethanoic acid

N-Methyl-2,3,7,8-tetramethoxy-5,6-dihydrobenzophenathridine-6-ethanoic acid

C24H25NO6 (423.1682)


   

coelenterazine

8-Benzyl-2-(4-hydroxybenzyl)-6-(4-hydroxyphenyl)imidazo-[1,2a]pyrazin-3(7H)-one

C26H21N3O3 (423.1583)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents

   

Carbidopa; Levodopa

(2S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid - 3-hydroxy-L-tyrosine (1:1)

C19H25N3O8 (423.1642)


   

7-Hydroxytrifluoperazine

10-[3-(4-methylpiperazin-1-yl)propyl]-8-(trifluoromethyl)-10H-phenothiazin-3-ol

C21H24F3N3OS (423.1592)


   

Coelenterazine

2-(4-Hydroxybenzyl)-6-(4-hydroxyphenyl)-8-benzyl-3,7-dihydroimidazo(1,2-a)pyrazin-3-one

C26H21N3O3 (423.1583)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents

   

[4,5-Bis(4-methoxyphenyl)-2-thiazolyl]-(4-methyl-1-piperazinyl)methanone

[4,5-Bis(4-methoxyphenyl)-2-thiazolyl]-(4-methyl-1-piperazinyl)methanone

C23H25N3O3S (423.1617)


D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   

Trifluoperazine sulfoxide

10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)-10H-5lambda4-phenothiazin-5-one

C21H24F3N3OS (423.1592)


   

8-benzyl-6-(4-hydroxy-benzyl)-2-(4-hydroxy-phenyl)-7H-imidazo[1,2-a]pyrazin-3-one|Oplophorus-Luciferin

8-benzyl-6-(4-hydroxy-benzyl)-2-(4-hydroxy-phenyl)-7H-imidazo[1,2-a]pyrazin-3-one|Oplophorus-Luciferin

C26H21N3O3 (423.1583)


   

ZINC100006452

ZINC100006452

C26H21N3O3 (423.1583)


   

13-Aethoxy-1,2,4-trimethoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin|13-ethoxy-1,2,4-trimethoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridine

13-Aethoxy-1,2,4-trimethoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin|13-ethoxy-1,2,4-trimethoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridine

C24H25NO6 (423.1682)


   

8-Acetonylcorynoline

8-Acetonylcorynoline

C24H25NO6 (423.1682)


   

(9R*,10S*,13R*)-9-hydroxy-3-methoxy-2-methyl-9-(3,4-dimethoxyphenyl)-14-oxa-biciclo[3.2.1]-octa[f]quinolone|helicterone A

(9R*,10S*,13R*)-9-hydroxy-3-methoxy-2-methyl-9-(3,4-dimethoxyphenyl)-14-oxa-biciclo[3.2.1]-octa[f]quinolone|helicterone A

C24H25NO6 (423.1682)


   

3-benzoyl-5-oxo-1-p-tolyl-pyrrolidine-2,2-dicarboxylic acid diethyl ester

3-benzoyl-5-oxo-1-p-tolyl-pyrrolidine-2,2-dicarboxylic acid diethyl ester

C24H25NO6 (423.1682)


   

Glu Phe Glu

Glu Phe Glu

C19H25N3O8 (423.1642)


   

Glu Glu Phe

Glu Glu Phe

C19H25N3O8 (423.1642)


   

NSC343026

NSC343026

C19H25N3O8 (423.1642)


   

His Met His

His Met His

C17H25N7O4S (423.1689)


   

Met His His

Met His His

C17H25N7O4S (423.1689)


   

Trifluoperazine (oxide)

Trifluoperazine (oxide)

C21H24F3N3OS (423.1592)


   

Ala Cys Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanoic acid

C15H29N5O5S2 (423.161)


   

Ala Cys Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanoic acid

C15H29N5O5S2 (423.161)


   

Ala Lys Cys Cys

(2R)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C15H29N5O5S2 (423.161)


   

Cys Ala Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-sulfanylpropanamido]hexanoic acid

C15H29N5O5S2 (423.161)


   

Cys Ala Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]hexanamido]-3-sulfanylpropanoic acid

C15H29N5O5S2 (423.161)


   

Cys Cys Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]propanamido]hexanoic acid

C15H29N5O5S2 (423.161)


   

Cys Cys Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanamido]propanoic acid

C15H29N5O5S2 (423.161)


   

Cys Lys Ala Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]propanamido]-3-sulfanylpropanoic acid

C15H29N5O5S2 (423.161)


   

Cys Lys Cys Ala

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanamido]propanoic acid

C15H29N5O5S2 (423.161)


   

Met His His

Met His His

C17H25N7O4S1 (423.1689)


   

Lys Ala Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C15H29N5O5S2 (423.161)


   

Lys Cys Ala Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]propanamido]-3-sulfanylpropanoic acid

C15H29N5O5S2 (423.161)


   

Lys Cys Cys Ala

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]propanoic acid

C15H29N5O5S2 (423.161)


   

His Met His

His Met His

C17H25N7O4S1 (423.1689)


   

Phe Glu Glu

Phe Glu Glu

C19H25N3O8 (423.1642)


   

His His Met

His His Met

C17H25N7O4S1 (423.1689)


   

7-Hydroxytrifluoperazine

7-Hydroxytrifluoperazine

C21H24F3N3OS (423.1592)


   

Trifluoperazine N-oxide

Trifluoperazine N-oxide

C21H24F3N3OS (423.1592)


   

Trifluoperazine N4-oxide

Trifluoperazine N4-oxide

C21H24F3N3OS (423.1592)


   

Trifluoperazine sulfoxide

Trifluoperazine sulfoxide

C21H24F3N3OS (423.1592)


   

FR122047

1-[[4,5-bis(4-methoxyphenyl)-2-thiazolyl]carbonyl]-4-methyl-piperazine, monohydrochloride

C23H25N3O3S (423.1617)


   

Oxazine 1 perchlorate

Phenoxazin-5-ium, 3,7-bis(diethylamino)-, perchlorate (1:1)

C20H26ClN3O5 (423.1561)


   

Terazosin hydrochloride

Terazosin hydrochloride

C19H26ClN5O4 (423.1673)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Terazosin hydrochloride is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist. Terazosin hydrochloride works by relaxing blood vessels and the opening of the bladder. Terazosin hydrochloride has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment[1][2][3].

   

(R)-1-(4-((2-methyloxiran-2-yl)methoxy)phenyl)-4-(4-(trifluoromethoxy)phenoxy)piperidine

(R)-1-(4-((2-methyloxiran-2-yl)methoxy)phenyl)-4-(4-(trifluoromethoxy)phenoxy)piperidine

C22H24F3NO4 (423.1657)


   

1,4-Dioxaspiro[4.5]decane-8-carboxylicacid,8-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-(9CI)

1,4-Dioxaspiro[4.5]decane-8-carboxylicacid,8-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-(9CI)

C24H25NO6 (423.1682)


   

Chz868

Chz868

C22H19F2N5O2 (423.1507)


   

(2Z)-8-benzyl-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methylidene]-7,8-dihydroimidazo[1,2-a]pyrazin-3-one

(2Z)-8-benzyl-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methylidene]-7,8-dihydroimidazo[1,2-a]pyrazin-3-one

C26H21N3O3 (423.1583)


   

Glu-Glu-Phe

Glu-Glu-Phe

C19H25N3O8 (423.1642)


   

Phe-Glu-Glu

Phe-Glu-Glu

C19H25N3O8 (423.1642)


   

3-(5-chloro-2-hydroxyphenyl)-3-phenyl-N-[(4-propan-2-yloxyphenyl)methyl]propanamide

3-(5-chloro-2-hydroxyphenyl)-3-phenyl-N-[(4-propan-2-yloxyphenyl)methyl]propanamide

C25H26ClNO3 (423.1601)


   

Glu-Phe-Glu

Glu-Phe-Glu

C19H25N3O8 (423.1642)


   

4-[2-[[8-Fluoro-5-(phenylmethyl)-[1,2,4]triazino[5,6-b]indol-3-yl]thio]ethyl]morpholine

4-[2-[[8-Fluoro-5-(phenylmethyl)-[1,2,4]triazino[5,6-b]indol-3-yl]thio]ethyl]morpholine

C22H22FN5OS (423.1529)


   

(2S,3R,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-1-[oxo(2-pyridinyl)methyl]-2-azetidinecarbonitrile

(2S,3R,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-1-[oxo(2-pyridinyl)methyl]-2-azetidinecarbonitrile

C26H21N3O3 (423.1583)


   

(2S,3R,4R)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-1-[oxo(2-pyridinyl)methyl]-2-azetidinecarbonitrile

(2S,3R,4R)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-1-[oxo(2-pyridinyl)methyl]-2-azetidinecarbonitrile

C26H21N3O3 (423.1583)


   

(2R,3R,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-1-[oxo(2-pyridinyl)methyl]-2-azetidinecarbonitrile

(2R,3R,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-1-[oxo(2-pyridinyl)methyl]-2-azetidinecarbonitrile

C26H21N3O3 (423.1583)


   

(2R,3R,4R)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-1-(pyridine-2-carbonyl)azetidine-2-carbonitrile

(2R,3R,4R)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-1-(pyridine-2-carbonyl)azetidine-2-carbonitrile

C26H21N3O3 (423.1583)


   

(2S,3S,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-1-[oxo(2-pyridinyl)methyl]-2-azetidinecarbonitrile

(2S,3S,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-1-[oxo(2-pyridinyl)methyl]-2-azetidinecarbonitrile

C26H21N3O3 (423.1583)


   

(2R,3S,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-1-(pyridine-2-carbonyl)azetidine-2-carbonitrile

(2R,3S,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-1-(pyridine-2-carbonyl)azetidine-2-carbonitrile

C26H21N3O3 (423.1583)


   

3-[4-[(1R,5S)-3-[1,3-benzodioxol-5-yl(oxo)methyl]-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

3-[4-[(1R,5S)-3-[1,3-benzodioxol-5-yl(oxo)methyl]-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

C26H21N3O3 (423.1583)


   

Met-His-His

Met-His-His

C17H25N7O4S (423.1689)


   

His-His-Met

His-His-Met

C17H25N7O4S (423.1689)


   

His-Met-His

His-Met-His

C17H25N7O4S (423.1689)


   

[4,5-Bis(4-methoxyphenyl)-2-thiazolyl]-(4-methyl-1-piperazinyl)methanone

[4,5-Bis(4-methoxyphenyl)-2-thiazolyl]-(4-methyl-1-piperazinyl)methanone

C23H25N3O3S (423.1617)


D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   

LPE 12:3;O2

LPE 12:3;O2

C17H30NO9P (423.1658)


   

ST 18:4;O7;Gly

ST 18:4;O7;Gly

C20H25NO9 (423.1529)


   

STF-31

STF-31

C23H25N3O3S (423.1617)


STF-31 is a selective inhibitor of glucose transporter 1 (GLUT1), with an IC50 of 1 μM. STF-31 is also a NAMPT inhibitor. STF-31 inhibits glucose uptake in renal cell carcinoma (RCC) 4 cells[1][2].

   

20-ethoxy-15,17,18-trimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaene

20-ethoxy-15,17,18-trimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaene

C24H25NO6 (423.1682)


   

(20r)-20-ethoxy-15,17,18-trimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaene

(20r)-20-ethoxy-15,17,18-trimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaene

C24H25NO6 (423.1682)


   

{2,3,7,8-tetramethoxy-5-methyl-6h-benzo[c]phenanthridin-6-yl}acetic acid

{2,3,7,8-tetramethoxy-5-methyl-6h-benzo[c]phenanthridin-6-yl}acetic acid

C24H25NO6 (423.1682)


   

8-benzyl-2-(4-hydroxyphenyl)-6-[(4-hydroxyphenyl)methyl]-7h-imidazo[1,2-a]pyrazin-3-one

8-benzyl-2-(4-hydroxyphenyl)-6-[(4-hydroxyphenyl)methyl]-7h-imidazo[1,2-a]pyrazin-3-one

C26H21N3O3 (423.1583)


   

[(6s)-2,3,7,8-tetramethoxy-5-methyl-6h-benzo[c]phenanthridin-6-yl]acetic acid

[(6s)-2,3,7,8-tetramethoxy-5-methyl-6h-benzo[c]phenanthridin-6-yl]acetic acid

C24H25NO6 (423.1682)


   

4-[(2-{2,4-bis[(1-hydroxyethylidene)amino]pteridin-6-yl}ethyl)(methyl)amino]benzoic acid

4-[(2-{2,4-bis[(1-hydroxyethylidene)amino]pteridin-6-yl}ethyl)(methyl)amino]benzoic acid

C20H21N7O4 (423.1655)